Compound Summary
Compound Information
sulfamethoxazole
Compound Name: | sulfamethoxazole |
Compound CID: | 5329 |
Synonyms: | sulfamethoxazole 723-46-6 Gantanol Sulphamethoxazole Sulfisomezole More... |
Iupac Name: | 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide |
InChI: | InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13) |
InChIKey: | JLKIGFTWXXRPMT-UHFFFAOYSA-N |
Canonical Smiles: | CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N |
Isomeric Smiles: | CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N |
Molecular Weight: | 253.28 |
Molecular Formula: | C10H11N3O3S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
sulfamethoxazole
Molecular Weight: | 253.28 |
Molecular Formula: | C10H11N3O3S |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 17 |
Complexity: | 346 |
Synonyms
sulfamethoxazole
| sulfamethoxazole | sulfamethoxazole |
|---|---|
sulfamethoxazole |
723-46-6 |
Gantanol |
Sulphamethoxazole |
Sulfisomezole |
Sulfamethoxazol |
Metoxal |
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide |
Sulfamethylisoxazole |
Simsinomin |
Radonil |
Sinomin |
Sulphamethoxazol |
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide |
Sulpha-methoxizole |
Bactrim |
Sulfamethalazole |
Azo-gantanol |
Sulphamethylisoxazole |
Urobak |
Ro 4-2130 |
3-Sulfanilamido-5-methylisoxazole |
Gantanol-DS |
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide |
Sulphisomezole |
5-Methyl-3-sulfanilamidoisoxazole |
MS 53 |
3-Sulphanilamido-5-methylisoxazole |
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- |
5-Methyl-3-sulphanil-amidoisoxazole |
3-(p-Aminophenylsulfonamido)-5-methylisoxazole |
5-Methyl-3-sulfanylamidoisoxazole |
N-(5-Methyl-3-isoxazolyl)sulfanilamide |
N1-(5-Methyl-3-isoxazolyl)sulfanilamide |
N-(5-Methylisoxazol-3-yl)sulphanilamide |
3-(para-Aminophenylsulphonamido)-5-methylisoxazole |
Sulmeprim |
Trimeth/Sulfa |
A047 |
SMX |
Sulfamethoxazole sodium |
UNII-JE42381TNV |
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide |
CHEBI:9332 |
N-(5-Methyl-3-isoxazole)sulfanilamide |
Sulfamethoxizole |
Ro 6-2580/11 |
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide |
Sulfanilamide, N-(5-methyl-3-isoxazolyl)- |
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- |
4-AMINO-N-(5-METHYL-3-ISOXAZOYL)BENZENESULFONAMIDE |
Bactrimel |
Gamazole |
MFCD00010546 |
CHEMBL443 |
N1-(5-Methylisoxazol-3-yl)sulfanilamide |
MLS000069732 |
JE42381TNV |
Sulfametoxazol |
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide |
Solfametossazolo |
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide |
5-Methyl-3-sulfonylamidoisoxazole |
STX-608 |
Sulfamethoxazolum |
NSC147832 |
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide |
NSC-147832 |
NCGC00016533-05 |
NCGC00186654-01 |
CAS-723-46-6 |
SMR000058223 |
DSSTox_CID_6064 |
Solfametossazolo DCIT |
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole |
DSSTox_RID_78001 |
DSSTox_GSID_26064 |
(4-aminophenyl)sulfonyl(5-methylisoxazol-3-yl)amine |
Sulfametoxazol INN-Spanish |
Sulfamethoxazolum INN-Latin |
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-, radical ion(1+) |
144930-01-8 |
CCRIS 567 |
HSDB 3186 |
SR-01000000217 |
EINECS 211-963-3 |
NSC 147832 |
BRN 0226453 |
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide |
Sulfanilamide, N(1)-(5-methyl-3-isoxazolyl)- |
08D |
Prestwick_453 |
ALBB-002089 |
Septran (Salt/Mix) |
Septrin (Salt/Mix) |
Sulfamethoxazole,(S) |
Eusaprim (Salt/Mix) |
Ro-4-2130 |
Spectrum_000994 |
Sulfamethoxazole(USAN) |
Opera_ID_882 |
Maybridge1_007190 |
Prestwick0_000177 |
Prestwick1_000177 |
Prestwick2_000177 |
Prestwick3_000177 |
Spectrum2_000788 |
Spectrum3_000584 |
Spectrum4_000345 |
Spectrum5_000982 |
Sulfamethoxazole USAN:USP:INN:BAN:JAN |
Epitope ID:114999 |
Co-trimoxazole (Salt/Mix) |
SCHEMBL3656 |
Oprea1_114486 |
Oprea1_285680 |
BSPBio_000073 |
BSPBio_002028 |
KBioGR_000749 |
KBioSS_001474 |
MLS001055354 |
MLS001074165 |
MLS006011871 |
BIDD:GT0731 |
DivK1c_000649 |
SPECTRUM1500550 |
SPBio_000896 |
SPBio_001994 |
ARONIS018156 |
BPBio1_000081 |
DTXSID8026064 |
component of Bactrim (Salt/Mix) |
GTPL10933 |
HMS502A11 |
HMS561O18 |
JLKIGFTWXXRPMT-UHFFFAOYSA- |
KBio1_000649 |
KBio2_001474 |
KBio2_004042 |
KBio2_006610 |
KBio3_001528 |
ZINC89763 |
EBD3403 |
N1-(5-methylisoxazol-3-yl)-4-aminobenzene-1-sulfonamide |
STX 608 |
WLN: T5NOJ C1 EMSWR DZ |
NINDS_000649 |
HMS1568D15 |
HMS1921A21 |
HMS2092K03 |
HMS2095D15 |
HMS2233L13 |
HMS3259E06 |
HMS3372M22 |
HMS3655O22 |
HMS3712D15 |
Pharmakon1600-01500550 |
BCP02881 |
HY-B0322 |
Sulfamethoxazole (JP17/USP/INN) |
Sulfamethoxazole, analytical standard |
Tox21_110480 |
Tox21_200353 |
BBL004554 |
BDBM50029770 |
CCG-40166 |
HTS001394 |
NSC757328 |
Ro-42130 |
s1915 |
SBB057675 |
SBB071655 |
STK007988 |
AKOS000200952 |
component of Azo Gantanol (Salt/Mix) |
Tox21_110480_1 |
BS-3542 |
DB01015 |
MCULE-1450176600 |
NC00537 |
NSC-757328 |
RP-2145 |
IDI1_000649 |
NCGC00016533-01 |
NCGC00016533-02 |
NCGC00016533-03 |
NCGC00016533-04 |
NCGC00016533-06 |
NCGC00016533-07 |
NCGC00016533-08 |
NCGC00016533-09 |
NCGC00016533-10 |
NCGC00016533-11 |
NCGC00016533-12 |
NCGC00016533-14 |
NCGC00021995-03 |
NCGC00021995-04 |
NCGC00021995-05 |
NCGC00257907-01 |
AC-11118 |
H463 |
ST024740 |
SY018888 |
BCP0726000283 |
N-(5-Methyl-3-isoxazolyl)-Sulfanilamide |
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide |
N1-(5-Methyl-3-isoxazolyl)sulphanilamide |
SBI-0051524.P003 |
DB-055629 |
AB00052099 |
BB 0242379 |
FT-0602616 |
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide |
ST51006798 |
SW196670-3 |
C07315 |
D00447 |
F12027 |
J10090 |
Sulfamethoxazole 100 microg/mL in Acetonitrile |
AB00052099-14 |
AB00052099-16 |
AB00052099_17 |
AB00052099_18 |
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide |
Q415843 |
Q-201762 |
SR-01000000217-2 |
SR-01000000217-3 |
Sulfamethoxazole, VETRANAL(TM), analytical standard |
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI) |
4-Amino-N-(5-methylisoxazol-3-yl)benzenesulphonamide |
BRD-K28494619-001-05-0 |
BRD-K28494619-001-15-9 |
BRD-K28494619-001-26-6 |
Z57198677 |
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide |
Sulfamethoxazole, British Pharmacopoeia (BP) Reference Standard |
Sulfamethoxazole, certified reference material, TraceCERT(R) |
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; SMX; SMZ |
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard |
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard |
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material |
129378-89-8 |
Experimental Data
sulfamethoxazole
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 400 | umol/L | 34 | S | N2 | 24034891 | Active | ||||||
| Caenorhabditis elegans | 100 | umol/L | 18 | S | N2 | 24034891 | Active | ||||||
| Caenorhabditis elegans | 200 | umol/L | 28 | S | N2 | 24034891 | Active |
Experimental Data Visualization
sulfamethoxazole
Statistics Data
sulfamethoxazole
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 34 | 1 | 3 |
Statistics Data Visualization
sulfamethoxazole
